J D Greenberg

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. doi request reprint Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, New York, NY Electronic address
    Am J Med 126:1089-98. 2013
  2. pmc Malignancy validation in a United States registry of rheumatoid arthritis patients
    Mark C Fisher
    Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA
    BMC Musculoskelet Disord 13:85. 2012
  3. doi request reprint A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, Department of Rheumatology, 301 East 17th Street, Suite 1410, New York, NY 10003, USA
    Ann Rheum Dis 71:1134-42. 2012
  4. doi request reprint Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
    Jeffrey D Greenberg
    Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Suite 1410, New York, NY 10003, USA
    Ann Rheum Dis 70:576-82. 2011
  5. ncbi request reprint The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk
    J D Greenberg
    New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Clin Exp Rheumatol 27:395-401. 2009
  6. pmc Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis
    Jeffrey D Greenberg
    Department of Rheumatology, New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Rheumatology (Oxford) 48:686-90. 2009
  7. pmc Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
    J D Greenberg
    New York University Hospital for Joint Diseases, New York, USA
    Ann Rheum Dis 69:380-6. 2010
  8. pmc Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Am J Med 121:532-8. 2008
  9. ncbi request reprint Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, New York, New York, USA
    Arthritis Rheum 53:12-7. 2005
  10. ncbi request reprint Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic
    A Mor
    Division of Rheumatology, Department of Medicine, New York University School of Medicine, Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003, USA
    Ann Rheum Dis 67:462-5. 2008

Research Grants

  1. Prognostic Genetic Biomarkers in Rheumatoid Arthritis
    Jeffrey Greenberg; Fiscal Year: 2007

Detail Information

Publications25

  1. doi request reprint Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, New York, NY Electronic address
    Am J Med 126:1089-98. 2013
    ..We compared disease activity and clinical outcomes across racial and ethnic groups using data from a large, contemporary US registry...
  2. pmc Malignancy validation in a United States registry of rheumatoid arthritis patients
    Mark C Fisher
    Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA
    BMC Musculoskelet Disord 13:85. 2012
    ..However, little is known on the accuracy of physician reported malignancies compared to pertinent medical record review in large cohort studies...
  3. doi request reprint A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, Department of Rheumatology, 301 East 17th Street, Suite 1410, New York, NY 10003, USA
    Ann Rheum Dis 71:1134-42. 2012
    ..To compare the effectiveness of anti-tumour necrosis factor (TNF) agents in biologically naive and 'switched' rheumatoid arthritis (RA) patients...
  4. doi request reprint Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
    Jeffrey D Greenberg
    Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Suite 1410, New York, NY 10003, USA
    Ann Rheum Dis 70:576-82. 2011
    ..To examine the association of cardiovascular events with tumour necrosis factor (TNF) α antagonist use compared with non-biological disease-modifying antirheumatic drug (DMARD) utilisation in patients with rheumatoid arthritis (RA)...
  5. ncbi request reprint The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk
    J D Greenberg
    New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Clin Exp Rheumatol 27:395-401. 2009
    ..To examine effects of the COX-2 inhibitor market withdrawals on NSAID utilization among patients at increased risk of gastrointestinal (GI) and cardiovascular (CV) toxicities...
  6. pmc Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis
    Jeffrey D Greenberg
    Department of Rheumatology, New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Rheumatology (Oxford) 48:686-90. 2009
    ....
  7. pmc Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
    J D Greenberg
    New York University Hospital for Joint Diseases, New York, USA
    Ann Rheum Dis 69:380-6. 2010
    ..To examine the association of methotrexate (MTX) and tumour necrosis factor (TNF) antagonists with the risk of infectious outcomes including opportunistic infections in patients with rheumatoid arthritis (RA)...
  8. pmc Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Am J Med 121:532-8. 2008
    ..The study objective was to investigate responsiveness according to whether patients satisfy eligibility criteria from randomized controlled trials of tumor necrosis factor (TNF) antagonists in a multicentered US cohort...
  9. ncbi request reprint Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, New York, New York, USA
    Arthritis Rheum 53:12-7. 2005
    ..To evaluate the effects of cardiovascular comorbidities and aspirin coprescription on cyclooxygenase (COX)-2 inhibitor (coxib) prescribing patterns among rheumatologists...
  10. ncbi request reprint Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic
    A Mor
    Division of Rheumatology, Department of Medicine, New York University School of Medicine, Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003, USA
    Ann Rheum Dis 67:462-5. 2008
    ..The goal of this study was to investigate the toxicity of MTX and INH treatment in patients with RA before initiating TNF antagonists...
  11. pmc Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib
    M E Farkouh
    Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1074, New York, NY 10029, USA
    Ann Rheum Dis 66:764-70. 2007
    ..However, evidence from prospective studies of currently available COX-2 inhibitors and non-selective NSAIDs is lacking in patients at high cardiovascular risk who are taking aspirin...
  12. ncbi request reprint Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, New York 10003, USA
    Arthritis Rheum 55:543-50. 2006
    ..To examine cyclooxygenase 2 inhibitor (coxib) utilization by rheumatologists for patients receiving nonsteroidal antiinflammatory drugs (NSAIDs) prior to the coxib market withdrawals...
  13. doi request reprint Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry
    Soumya M Reddy
    New York University School of Medicine Hospital for Joint Diseases, New York, USA
    J Rheumatol 37:2566-72. 2010
    ..To compare disease activity, radiographic features, and bone density in psoriatic arthritis (PsA) and rheumatoid arthritis (RA) matched cohorts...
  14. doi request reprint The role of microRNA in rheumatoid arthritis and other autoimmune diseases
    Victoria Furer
    Division of Rheumatology, Department of Medicine, NYU School of Medicine NYU Hospital for Joint Diseases, New York, NY 10009, USA
    Clin Immunol 136:1-15. 2010
    ..We conclude with a discussion of the implications of miRNA biology in rheumatoid arthritis and other autoimmune disorders...
  15. ncbi request reprint TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries
    Adeel Nasir
    Division of Rheumatology, NYU Hospital for Joint Diseases, and New York University School of Medicine, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 65:178-81. 2007
    ..This review discusses the emerging evidence from observational registries on the risk of infection, malignancy, and CV outcomes associated with TNF antagonists...
  16. pmc Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA
    Y Lai
    Institute of Pathogenic Biology, Shandong University School of Medicine, Jinan, Shandong 250012, PR China
    Osteoarthritis Cartilage 20:854-62. 2012
    ..The study aimed determining whether assessment of cartilage oligomeric matrix protein (COMP) degradation products could serve as a serological disease course and therapeutic response predictor in arthritis...
  17. doi request reprint Assessing infection risk with biologic agents in RA: methodological challenges
    Mark C Fisher
    New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Nat Rev Rheumatol 5:288-91. 2009
    ....
  18. ncbi request reprint Predicting response to TNF antagonists in rheumatoid arthritis: the promise of pharmacogenetics research using clinical registries
    Jeffrey D Greenberg
    NYU Hospital for Joint Diseases, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 65:139-42. 2007
    ..This review focuses on published pharmacogenetic studies of TNF antagonists and discusses related methodologic issues for pharmacogenetic research using clinical registries...
  19. pmc Dendritic cells as targets for therapy in rheumatoid arthritis
    Shaukat Khan
    Cancer Institute, New York University Langone Medical Center, and New York University Hospital for Joint Diseases, New York, NY 10016, USA
    Nat Rev Rheumatol 5:566-71. 2009
    ..Studies to validate these approaches to ameliorate autoimmunity will be necessary before their application in the clinic...
  20. ncbi request reprint Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis
    Jeffrey D Greenberg
    Department of Rheumatology, NYU Hospital for Joint Diseases, New York, New York, USA
    J Rheumatol 35:770-5. 2008
    ..We estimated the prevalence of anergy in RA and evaluated different methods to detect MTB exposure...
  21. ncbi request reprint Are NSAIDs and selective cyclo-oxygenase 2 inhibitors associated with increased risk of myocardial infarction?
    Steven B Abramson
    New York University Hospital for Joint Diseases, New York, NY, USA
    Nat Clin Pract Rheumatol 4:182-3. 2008
    ..COX2 inhibitors were, however, associated with a reduced risk of serious gastrointestinal events. An analysis of previous systematic reviews showed increased risks of MI associated with rofecoxib and celecoxib...
  22. ncbi request reprint Reimbursement denial and reversal by health plans at a university hospital
    Jeffrey D Greenberg
    Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, USA
    Am J Med 117:629-35. 2004
    ..Denial and downgrading of reimbursement for hospital days are two strategies utilized by health plans to maintain profitability. The goal of this study was to describe patterns of discounted reimbursement at a university hospital...
  23. doi request reprint The role of drug and disease registries in rheumatic disease epidemiology
    Joel M Kremer
    Albany Medical College, 1367 Washington Avenue, Albany, NY 12206, USA
    Curr Opin Rheumatol 20:123-30. 2008
    ..This review highlights the present state of efforts at registry implementation which exist internationally. These efforts are contrasted with those in the USA...
  24. ncbi request reprint Dual-system utilization affects regional variation in prevention quality indicators: the case of amputations among veterans with diabetes
    Chin Lin Tseng
    Center for Healthcare Knowledge Management, Veterans Affairs New Jersey HealthCare System, East Orange, NJ 07018, USA
    Am J Manag Care 10:886-92. 2004
    ..To determine the impact of dual-system utilization by veterans on regional variation in lower-extremity amputation rates...
  25. ncbi request reprint Determinants of sustained uncontrolled blood pressure in a national cohort of persons with diabetes
    Jeffrey D Greenberg
    Department of Veterans Affairs New Jersey Healthcare System, East Orange, New Jersey 07018, USA
    Am J Hypertens 19:161-9. 2006
    ..In this study we evaluated the prevalence and determinants of severe, sustained, uncontrolled hypertension in a national cohort of persons with diabetes...

Research Grants2

  1. Prognostic Genetic Biomarkers in Rheumatoid Arthritis
    Jeffrey Greenberg; Fiscal Year: 2007
    ..Pharmacogenetic studies that can identify genetic biomarkers to "personalize" the likelihood of clinical response to targeted BRMs, as well as the risk of adverse outcomes, will represent a major advance for the treatment of RA. ..